InvestSMART

HeraMED Limited (ASX: HMD) - Announcements

Current share price for HMD : $0.036 0.001 (2.70%)+

ASX company news and announcements for HeraMED Limited (HMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All HeraMED Limited (HMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than HeraMED Limited (HMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for HeraMED Limited (HMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$42 Exclusive Agreement Executed with Australian Distributor 8 May 2020 8:25AM $0.120 $0.036 fallen by 70%
$42 Quarterly Activities and CashFlow Report 1 May 2020 8:15AM $0.120 $0.036 fallen by 70%
$42 New FDA Recommendations - Fetal & Maternal Monitoring 27 Apr 2020 8:33AM $0.120 $0.036 fallen by 70%
$42 Appendix 2A & Cleansing Notice 17 Apr 2020 7:12PM $0.130 $0.036 fallen by 72.31%
$42 US Market Entry Strategy Update 7 Apr 2020 9:15AM $0.150 $0.036 fallen by 76%
$42 US Market Strategy Presentation - April 2020 7 Apr 2020 8:35AM $0.150 $0.036 fallen by 76%
$42 Appendix 4G and Corporate Governance Statement 27 Mar 2020 7:40PM $0.120 $0.036 fallen by 70%
$42 Annual Report to shareholders 27 Mar 2020 7:36PM $0.120 $0.036 fallen by 70%
$42 HMD Update & COVID-19 Opportunities Conference Call 25 Mar 2020 9:59AM $0.070 $0.036 fallen by 48.57%
$42 Company Update - COVID-19 To Accelerate Global Opportunities 24 Mar 2020 9:21AM $0.059 $0.036 fallen by 38.98%
$42 HeraCARE Product Development Update 2 Mar 2020 8:47AM $0.105 $0.036 fallen by 65.71%
$42 HeraCARE Presentation - March 2020 2 Mar 2020 8:40AM $0.105 $0.036 fallen by 65.71%
$42 Change of Company Secretary & Registered Address 2 Mar 2020 8:32AM $0.105 $0.036 fallen by 65.71%
$42 Appendix 4E & Preliminary Final Report 27 Feb 2020 9:07AM $0.140 $0.036 fallen by 74.29%
$42 Cleansing Notice 20 Feb 2020 8:21AM $0.145 $0.036 fallen by 75.17%
$42 Appendix 2A 19 Feb 2020 7:35PM $0.145 $0.036 fallen by 75.17%
$42 Proposed issue of Securities - HMD 19 Feb 2020 4:47PM $0.145 $0.036 fallen by 75.17%
$42 Results of General Meeting 19 Feb 2020 3:55PM $0.145 $0.036 fallen by 75.17%
$42 HeraBEAT Plus Clinical Trial Study Details 17 Feb 2020 9:43AM $0.165 $0.036 fallen by 78.18%
$42 Mayo Clinic clinical study to evaluate HeraBEAT Plus 10 Feb 2020 8:21AM $0.170 $0.036 fallen by 78.82%
$42 HeraMED appoints US General Manager of Operations 3 Feb 2020 8:19AM $0.165 $0.036 fallen by 78.18%
$42 December Quarter Activities Report and Appendix 4C 30 Jan 2020 8:43AM $0.160 $0.036 fallen by 77.50%
$42 Notice of Extraordinary General Meeting and Proxy Form 20 Jan 2020 4:40PM $0.190 $0.036 fallen by 81.05%
$42 HMD accesses unique pregnancy database to strengthen OrionAI 20 Jan 2020 12:01PM $0.175 $0.036 fallen by 79.43%
$42 Response to ASX Aware Query 20 Jan 2020 10:28AM $0.175 $0.036 fallen by 79.43%

426 - 450 of 543 results

Page 18 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.